PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to assist employers,…
Ensure Your Consultant and Procurement are Best-in-Class Ten to fifteen years ago, pharmacy benefit manager (PBM) procurements were relatively simple: plan sponsors would go out…
Leverage Integrated Data to Inform Better Benefit Decisions An estimated 22 million U.S. adults are affected by a chronic liver condition called metabolic dysfunction-associated steatohepatitis…
Will This Gene Therapy Break Payers’ Budgets? Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a severe, inherited skin disorder that has no cure, and until recently,…
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges as they…
New Research Reveals Strategic Approaches to Balancing Member Access and Affordability with Pharmacy Spend Control DALLAS, TX – June 10, 2025 – Pharmaceutical Strategies Group…
Join us for an in-depth exploration of one of the most impactful developments in prescription drug benefits: GLP-1 medications for type 2 diabetes and obesity…
Maximizing Value through Medical Drug Rebate Strategies PSG’s 2025 Trends in Specialty Drug Benefits Report, released in late April, revealed several unexpected and impactful…
Mitigate Risk with a Smart MPPP Program Audit The world of Medicare Part D underwent a significant transformation with the introduction of the Medicare…
Understand Important Components of a Modular PBA Strategy for Employers In 2023, Blue Shield of California (BSC) announced a new pharmacy supply chain model…
